Biostatisticians should be involved much more than we currently are in the forming of a data collection strategy in clinical trials. Too often we are left in the margins of case report form design, and so we have to deal with the consequences of decisions made by those who don't live downstream of the data collection process.
I have a suspicion that clinical trials isn't the only place where this principle applies.
